Dr. David Heiden, MD

Dr. Heiden practices at Pacific Eye Associates, a Medical Corporation in San Francisco, California.

Dr. Heiden's NPI, 1053312108, was assigned on August 10, 2005. Dr. Heiden graduated from New York Medical College in 1972. Dr. Heiden holds California license G25331.

Dr. Heiden's primary practice is Pacific Eye Associates, a Medical Corporation, at 2100 Webster St, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 923-3007.

Dr. Heiden's primary practice is Pacific Eye Associates, a Medical Corporation in San Francisco, California. Dmand AI also links Dr. Heiden to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heiden practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Heiden's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Heiden is board certified in internal medicine by the American Board of Internal Medicine. Dr. Heiden is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Heiden treats.

CMS data shows 847 Medicare services from Dr. Heiden across 7 procedure codes in 2024, for 437 Medicare patients. Medicare paid $60,479 for them. Every service was in an office.

CMS counts 437 Medicare patients who saw Dr. Heiden in 2024. The largest group is 75 to 84, with 178 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Heiden's median patient age at 73, with 52% women.

In 2024, Dr. Heiden wrote 821 Medicare Part D claims for 136 patients. 46% of them were for generic drugs. CMS names the drug for 726 of them, across 18 drugs with 11 or more claims each, at $126,039 in total drug cost. In 2023, CMS named 992 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Heiden for performance year 2024, reported as part of a group. Dr. Heiden accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Dr. Heiden, published from 2011 to 2020. 2011 was the busiest year, with 7. The most frequent topics are Cytomegalovirus Retinitis, AIDS-Related Opportunistic Infections and Thailand. Dr. Heiden has published most often in Br J Ophthalmol. Dr. Heiden's most frequent co-authors are Jeremy David Keenan, MD, Todd Paul Margolis, MD and Michael T. Yen, MD.

CMS Open Payments shows 81 general payments to Dr. Heiden from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Carl Zeiss Meditec USA, Inc. paid the most, $912.

Dmand AI lists 1 award for Dr. Heiden.

Dr. Heiden graduated from New York Medical College in 1972. Dr. Heiden is a member of AAO.

Dr. Heiden is in network with 15 carriers, including United Healthcare, Elevance and HCSC. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.